Intrinsiqq
Stevanato Group S.p.A. logoStevanato Group S.p.A.STVN
$18.90-1.82%
Stevanato Group S.p.A. logo

Stevanato Group S.p.A.

STVN

$18.90

-$0.35 (-1.82%)

⊜ Compare
ProfitabilitySolid marginsGrowthSteady growthCash FlowCash burnValuationNot cheap
What stands out

16.76% operating margin is respectable but not wide. ROIC at 7.76%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.

What's changing

Revenue grew 7.4%, steady but not accelerating.

What deserves caution

At 35x earnings, the current multiple leaves limited room for execution misses or growth deceleration. Net debt of €338M represents 30.6x FCF, leverage limits flexibility.

Valuation context

35.0x earnings. Not cheap, the quality is already reflected in the price. Upside from here requires either margin expansion or growth re-acceleration, not just continuation.

Price History

-21.6%

Valuation & Multiples

Based on TTM earnings · Diluted shares

Market Cap€4.59B
EPS€0.48
P/E35.03
P/FCF-149.32
EV/EBITDA16.00
FCF Yield—
Div. Yield0.37%
Net Debt/FCF-11.0x
52-Week Range
$13.43$27.61

Profitability & Returns

Revenue (TTM)

€1.23B

▲ +7.4% YoY

Net Income (TTM)

€135M

▲ +18.7% YoY

Op. Margin

17.37%

▲ +2.2pp YoY

ROIC

7.76%

▲ +0.7pp YoY

Cash Flow & Balance Sheet

FCF (TTM)

-€31M

▲ +107.0% YoY

Op. Cash Flow (TTM)

€249M

▲ +28.6% YoY

Net Debt

€338M

Cash & Equiv.

€131M

3Y CAGR: +6.4%

Continue Research

Is Stevanato Group S.p.A. (STVN) overvalued?

At a P/E of 35.0, Stevanato Group S.p.A. (STVN)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.

On quality, Stevanato Group S.p.A. scores 15/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 0.4%; see dividend safety for coverage and history. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.

Frequently asked

Is Stevanato Group S.p.A. a high-quality business?+

Stevanato Group S.p.A. scores 15 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a 17.4% operating margin and a 7.8% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.

Does Stevanato Group S.p.A. (STVN) pay a dividend, and how much?+

Yes, Stevanato Group S.p.A. pays a regular dividend of about €0.06 per share per year (typically in quarterly installments), a yield of roughly 0.4% at the current price. That is a payout ratio of about 12.6% of earnings, so the dividend is amply covered by earnings. Stevanato Group S.p.A. has grown the dividend at roughly 6.5% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For STVN's full payout history, growth streak and dividend-safety score, see the dividends tab.

Is Stevanato Group S.p.A. a good stock to buy right now?+

That depends on valuation and quality together, not either alone. you should weigh STVN's valuation and scores 15/100 on quality (lower-quality). It also yields about 0.4%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.

Related stocks: Medical Instruments & Supplies

Spot a number that looks wrong?

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.